SCHEMBL17666367

SCHEMBL17666367

c1ccc(Nc2ccc(-c3ccc(Nc4ccc(Cc5ccc(Nc6ccc(-c7ccc(Nc8ccccc8)cc7)cc6)cc5)cc4)cc3)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.59
HSD17B10 Q99714 6/20 0.59
ALOX12 P18054 4/20 0.59
TSHR P16473 4/20 0.59
L3MBTL1 Q9Y468 3/20 0.59
TDP1 Q9NUW8 3/20 0.59
ALOX15 P16050 3/20 0.59
MAPK1 P28482 2/20 0.59
PTGS1 P23219 1/20 0.59
SLC6A2 P23975 1/20 0.59
PTGS2 P35354 1/20 0.59
HTR2B P41595 1/20 0.59
CYP3A4 P08684 5/20 0.48
MAPT P10636 4/20 0.48
HPGD P15428 2/20 0.48
HTT P42858 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
CALM1 P0DP23 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18416527 0.95 CALM1 (0.55) ALDH1A1HSD17B10ALOX12TSHRL3MBTL1
SCHEMBL9418470 0.93 CALM1 (0.52) ALDH1A1HSD17B10ALOX12TSHRL3MBTL1
SCHEMBL8622727 0.93 ALDH1A1 (0.68) ALDH1A1HSD17B10ALOX12TSHRL3MBTL1
SCHEMBL13308523 0.93 ALDH1A1 (0.68) ALDH1A1HSD17B10ALOX12TSHRL3MBTL1
SCHEMBL19187359 0.91 ALDH1A1 (0.65) ALDH1A1HSD17B10ALOX12TSHRL3MBTL1
SCHEMBL25557237 0.91 ALDH1A1 (0.65) ALDH1A1HSD17B10ALOX12TSHRL3MBTL1
SCHEMBL284700 0.88 CALM1 (0.63) ALDH1A1HSD17B10ALOX12TSHRL3MBTL1
Diphenylmethane SCHEMBL2309364 0.85 HSD17B10 (0.67) ALDH1A1HSD17B10ALOX12TSHRL3MBTL1
SCHEMBL17965666 0.85 ALDH1A1 (0.81) ALDH1A1HSD17B10ALOX12TSHRL3MBTL1
SCHEMBL2852700 0.85 ALDH1A1 (0.81) ALDH1A1HSD17B10ALOX12TSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240244882-A1 DISPLAY DEVICE AND MANUFACTURING METHOD OF DISPLAY DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2024-07-18 US disclosed
US-20230403920-A1 METHOD OF MANUFACTURING DISPLAY PANEL AND THE DISPLAY PANEL SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-12-14 US disclosed
US-20230292544-A1 Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-09-14 US disclosed
US-20230276700-A1 Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-08-31 US disclosed
WO-2016052252-A1 CHARGE-TRANSPORTING VARNISH 日産化学工業株式会社 2016-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230276700-A1 Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device SLC43A1, SLC7A5, SLCO4C1 ALDH1A1 642/4885HSD17B10 1065/4885ALOX12 961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.